Pharmaceutical, BioTech Product Launches and Technology Innovations

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, it has launched Fosaprepitant for Injection and Fulvestrant Injection in the United States.

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient™. The standardized  and automated platform streamlines the assessment and validation of large molecules, which significantly reduces drug development timelines and resource costs.

Organon & Co.  Samsung Bioepis Co., Ltd.  that HADLIMA™ (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab), is now available to patients in the United States.

Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of Fluphenazine Hydrochloride Tablets, USP in 1 mg, 2.5 mg, 5 mg, and 10 mg strengths.

Microba Life Sciences Limited, a precision microbiome company, is pleased to announce that it’s next generation testing product range, MetaXplore™ has been launched to healthcare professionals in Australia under a new brand, Co-Biome™.